155 related articles for article (PubMed ID: 9600456)
21. Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency.
Fanin M; Anichini A; Cassandrini D; Fiorillo C; Scapolan S; Minetti C; Cassanello M; Donati MA; Siciliano G; D'Amico A; Lilliu F; Bruno C; Angelini C
Clin Genet; 2012 Sep; 82(3):232-9. PubMed ID: 21913903
[TBL] [Abstract][Full Text] [Related]
22. Novel mutations in CPT 1A define molecular heterogeneity of hepatic carnitine palmitoyltransferase I deficiency.
Bennett MJ; Boriack RL; Narayan S; Rutledge SL; Raff ML
Mol Genet Metab; 2004 May; 82(1):59-63. PubMed ID: 15110323
[TBL] [Abstract][Full Text] [Related]
23. Carnitine palmitoyltransferase II deficiency: structure of the gene and characterization of two novel disease-causing mutations.
Verderio E; Cavadini P; Montermini L; Wang H; Lamantea E; Finocchiaro G; DiDonato S; Gellera C; Taroni F
Hum Mol Genet; 1995 Jan; 4(1):19-29. PubMed ID: 7711730
[TBL] [Abstract][Full Text] [Related]
24. Severe infantile type of carnitine palmitoyltransferase II (CPT II) deficiency due to homozygous R503C mutation.
Spiegel R; Shaag A; Gutman A; Korman SH; Saada A; Elpeleg O; Shalev SA
J Inherit Metab Dis; 2007 Apr; 30(2):266. PubMed ID: 17372854
[TBL] [Abstract][Full Text] [Related]
25. Clinical and biochemical heterogeneity in an Italian family with CPT II deficiency due to Ser 113 Leu mutation.
Rafay MF; Murphy EG; McGarry JD; Kaufmann P; DiMauro S; Tein I
Can J Neurol Sci; 2005 Aug; 32(3):316-20. PubMed ID: 16225172
[TBL] [Abstract][Full Text] [Related]
26. CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency.
Isackson PJ; Bennett MJ; Lichter-Konecki U; Willis M; Nyhan WL; Sutton VR; Tein I; Vladutiu GD
Mol Genet Metab; 2008 Aug; 94(4):422-427. PubMed ID: 18550408
[TBL] [Abstract][Full Text] [Related]
27. Abbreviated half-lives and impaired fuel utilization in carnitine palmitoyltransferase II variant fibroblasts.
Yao M; Cai M; Yao D; Xu X; Yang R; Li Y; Zhang Y; Kido H; Yao D
PLoS One; 2015; 10(3):e0119936. PubMed ID: 25781464
[TBL] [Abstract][Full Text] [Related]
28. Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency.
Joshi PR; Deschauer M; Zierz S
Wien Klin Wochenschr; 2012 Dec; 124(23-24):851-4. PubMed ID: 23184072
[TBL] [Abstract][Full Text] [Related]
29. Novel mutation in the CPT II gene in a child with periodic febrile myalgia and myoglobinuria.
Bruno C; Bado M; Minetti C; Cordone G; DiMauro S
J Child Neurol; 2000 Jun; 15(6):390-3. PubMed ID: 10868782
[TBL] [Abstract][Full Text] [Related]
30. Newborn screening for carnitine palmitoyltransferase II deficiency using (C16+C18:1)/C2: Evaluation of additional indices for adequate sensitivity and lower false-positivity.
Tajima G; Hara K; Tsumura M; Kagawa R; Okada S; Sakura N; Maruyama S; Noguchi A; Awaya T; Ishige M; Ishige N; Musha I; Ajihara S; Ohtake A; Naito E; Hamada Y; Kono T; Asada T; Sasai H; Fukao T; Fujiki R; Ohara O; Bo R; Yamada K; Kobayashi H; Hasegawa Y; Yamaguchi S; Takayanagi M; Hata I; Shigematsu Y; Kobayashi M
Mol Genet Metab; 2017 Nov; 122(3):67-75. PubMed ID: 28801073
[TBL] [Abstract][Full Text] [Related]
31. Molecular basis of hepatic carnitine palmitoyltransferase I deficiency.
IJlst L; Mandel H; Oostheim W; Ruiter JP; Gutman A; Wanders RJ
J Clin Invest; 1998 Aug; 102(3):527-31. PubMed ID: 9691089
[TBL] [Abstract][Full Text] [Related]
32. Identification of four novel mutations in patients with carnitine palmitoyltransferase II (CPT II) deficiency.
Yang BZ; Ding JH; Dewese T; Roe D; He G; Wilkinson J; Day DW; Demaugre F; Rabier D; Brivet M; Roe C
Mol Genet Metab; 1998 Aug; 64(4):229-36. PubMed ID: 9758712
[TBL] [Abstract][Full Text] [Related]
33. Characterization of compound missense mutation and deletion of carnitine palmitoyltransferase II in a patient with adenovirus-associated encephalopathy.
Yao D; Yao M; Yamaguchi M; Chida J; Kido H
J Med Invest; 2011 Aug; 58(3-4):210-8. PubMed ID: 21921422
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatocardiomuscular expression.
Bonnefont JP; Taroni F; Cavadini P; Cepanec C; Brivet M; Saudubray JM; Leroux JP; Demaugre F
Am J Hum Genet; 1996 May; 58(5):971-8. PubMed ID: 8651281
[TBL] [Abstract][Full Text] [Related]
35. Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients.
Taroni F; Verderio E; Dworzak F; Willems PJ; Cavadini P; DiDonato S
Nat Genet; 1993 Jul; 4(3):314-20. PubMed ID: 8358442
[TBL] [Abstract][Full Text] [Related]
36. Myopathy due to carnitine palmitoyltransferase II deficiency: updating genetic aspects of the first publication in Brazil.
Lorenzoni PJ; Kay CSK; Ducci RD; Fustes OJH; Rodrigues PRDVP; Arndt RC; Scola RH; Werneck LC
Arq Neuropsiquiatr; 2024 Feb; 82(2):1-4. PubMed ID: 38395422
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic variability among first-degree relatives with carnitine palmitoyltransferase II deficiency.
Vladutiu GD; Bennett MJ; Fisher NM; Smail D; Boriack R; Leddy J; Pendergast DR
Muscle Nerve; 2002 Oct; 26(4):492-8. PubMed ID: 12362414
[TBL] [Abstract][Full Text] [Related]
38. Biochemical and molecular correlations in carnitine palmitoyltransferase II deficiency.
Vladutiu GD
Muscle Nerve; 1999 Jul; 22(7):949-51. PubMed ID: 10398218
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis in Spanish patients with muscle carnitine palmitoyltransferase deficiency.
Martín MA; Rubio JC; De Bustos F; Del Hoyo P; Campos Y; García A; Börnstein B; Cabello A; Arenas J
Muscle Nerve; 1999 Jul; 22(7):941-3. PubMed ID: 10398215
[TBL] [Abstract][Full Text] [Related]
40. Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach.
Joshi PR; Zierz S
Molecules; 2020 Apr; 25(8):. PubMed ID: 32295037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
